A Study of Safety, Tolerability and Preliminary Efficacy of NTS071 in Subjects With Advanced Solid Tumors Harboring a TP53 Y220C Mutation

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Advanced Solid Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Next Oncology, San Antonio, Texas, United States
Shanghai, Shanghai, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Breast Cancer · Endometrial Cancer · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Orlando, United States · Boston, United States

Study of SGN1 in Patients With Advanced Solid Tumor

Advanced Solid Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Gilbert, United States · Orange, United States

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

Solid Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Duarte, United States · La Jolla, United States

A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration

Advanced Solid Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Hefei, China · Beijing, China